Navigation Links
Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
Date:11/23/2009

NOVATO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP) today announced the presentation of clinical trial data on NGX426, the Company's orally administered, non-opioid, AMPA/kainate receptor antagonist, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, held on November 20-21 in San Francisco. The results of the study led by Mark Wallace, M.D., Professor of Clinical Anesthesiology at the Center for Pain Medicine of the University of California at San Diego, suggested that NGX426 could be effective in a variety of neuropathic pain states, which are caused by damage to or dysfunction of the peripheral or central nervous system rather than stimulation of pain receptors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO )

The objective of the single center, double-blind, randomized study conducted by Dr. Wallace was to demonstrate that the orally administered prodrug NGX426, maintains the analgesic effect previously shown for the active moiety, tezampanel. Using a cross-over design, a total of 18 study subjects received single doses of 90 mg of NGX426, 150 mg of NGX426 or placebo in each of three treatment periods. Pain was induced by injecting 250 ug (microgram) of capsaicin under the skin of the forearm at 30 minutes and 120 minutes after dosing.

The 150 mg dose showed statistically significant reductions in spontaneous pain versus placebo after the 30 minute and 120 minute capsaicin injection time points. At the 150 mg dose, reductions in elicited pain were also statistically significant versus placebo. The 90 mg dose of NGX426 showed statistical significance versus placebo after the 30 minut
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Provides Update of Product Programs
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
5. Raptor Pharmaceuticals Provides Update on Targeting Platforms
6. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
9. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
10. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
11. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Lazarus Effect, a medical device company ... facilitate removal of blood clots, announced the closing of ... support EU commercialization of several approved Lazarus Effect devices, ... and Lazarus Cover™ in the United States ... in the value of our novel, platform technology as ...
(Date:7/31/2014)... Colo. , July 31, 2014  Cannabis ... in cannabis formulation-based drug development and related consulting, ... production of multiple strains of cannabis and European ... to select the best strains for development of ... the cannabis formulations to market for critical ailments ...
(Date:7/31/2014)... July 31, 2014 For the first time, ... the implantation of the SynCardia temporary Total Artificial Heart ... video posted on the Journal of Visualized Experiments website. ... the paper on the SynCardia Total Artificial Heart implantation ... accompanies "Implantation of the SynCardia Total Artificial Heart," a ...
Breaking Medicine Technology:Lazarus Effect Closes $5 Million Financing 2Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
(Date:7/31/2014)... If you have asthma, you may have an asthma ... recognize and respond to changes and understand when symptoms are ... green zone, you,re doing well, yellow means your asthma has ... urgent care. New guidelines are now available to help your ... green and away from the red zone. , "Management of ...
(Date:7/31/2014)... July 31, 2014 Developer Jamestown, L.P., ... on its Ponce City Market project in Atlanta’s Old ... Roebuck & Company building into best-in-class office, housing, and ... reviewed Jamestown’s experience with their construction webcam service to ... Jamestown wanted a construction camera for monitoring ...
(Date:7/31/2014)... Hoping to attract new customers who are looking for a ... ready to ship out free samples of product. A form ... offer fast and easy: http://www.nutrigold.com/Free-Samples , According to ... know that every time customers purchase one of our products, ... own health or the health of a loved one and ...
(Date:7/31/2014)... Ce-Classes.com has announced that they are ... professionals, a Systematic Review of Sexual Satisfaction . ... the International Journal of Clinical and Health Psychology. , ... a need to have accurate information about sexual satisfaction ... possible. The material provides a systematic review of ...
(Date:7/31/2014)... 2014 Dr. Stewart Shofner of ... first surgeons in the United States to successfully treat glaucoma ... smallest medical device ever approved by the FDA. Dr. ... the benefits of using a procedure known as Selective Laser ... and his colleagues now recognize that this procedure is a ...
Breaking Medicine News(10 mins):Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 2Health News:OxBlue Construction Webcam Proves Valuable Tool for Developer, Consumers on Historic Ponce City Market Project 3Health News:NutriGold Launches Product Samples Page for its Supplements 2Health News:NutriGold Launches Product Samples Page for its Supplements 3Health News:Company Provides New Course on Sexual Satisfaction 2Health News:Company Provides New Course on Sexual Satisfaction 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 2Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 3Health News:Nashville’s Top Eye Surgeon, Dr. Stewart Shofner Successfully Treats Glaucoma Patients Using a Procedure Known as Selective Laser Trabeculoplasty (SLT) 4
... Mass. (February 10, 2008) Unlike the rest of the ... That quirk dates back to the time when mammals began ... have red cells that contain nuclei that are inactive. Losing ... oxygen-carrying hemoglobin, thus enabling more oxygen to be transported in ...
... pose deadly burden , , SUNDAY, Feb. 10 (HealthDay News) ... doctors have long been familiar with this curious but ... there,s a greater likelihood that the surviving spouse will ... better understanding of the forces at work, realizing problems ...
... in the Government ... AIDS System, NEW ... its strong support for a Global,Fund to Fight AIDS, Tuberculosis and Malaria ... (WB) concerning,the second phase of National AIDS Control Programme (NACO) projects,implemented throughout ...
... Day - What better Valentine,s Day gift than the,"gift ... Saturn,retailers nationwide have held more than 1,900 community donor ... local blood center partners,as part of Saturn National Donor ... the launch will be hosted by,Cavender,s Saturn of San ...
... Antidepressant medications,which increase serotonin neurotransmitter levels can ... depression, impulsivity and,suicide risk in depressed patients, ... serotonin enhancement medications to dopamine,deficient patients, patients ... Dr. Rick Sponaugle, Medical Director of Florida ...
... ev3 Inc. (Nasdaq:,EVVV), a global endovascular device company, today ... as Chief Scientist and,from the company,s board of directors ... years, few people have shaped the treatment of,cardiovascular disease ... and vision for improving the lives of patients worldwide," ...
Cached Medicine News:Health News:How red blood cells nuke their nuclei 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 2Health News:Spouse's Sickness Bodes Ill for Partner's Health 3Health News:AIDS Healthcare Foundation Shares World Bank, Global Fund Concerns Over Alleged Corruption at India's NACO 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 3Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 2Health News:Antidepressants Can Increase Depression, Impulsivity and Suicide Risk by Decreasing Dopamine 3
Cushing Little Joker periosteal elevators, solid handle, blade width 1/4" (6 mm), length 7 1/2" (191 mm)....
Molt 9 periosteal elevators....
Alexander periosteal elevators....
Lambotte periosteal elevators....
Medicine Products: